IBDEI0GA ; ; 09-AUG-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,20595,1,4,0)
 ;;=4^A81.09
 ;;^UTILITY(U,$J,358.3,20595,2)
 ;;=^5000410
 ;;^UTILITY(U,$J,358.3,20596,0)
 ;;=A81.00^^55^808^9
 ;;^UTILITY(U,$J,358.3,20596,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20596,1,3,0)
 ;;=3^Creutzfeldt-Jakob Disease,Unspec
 ;;^UTILITY(U,$J,358.3,20596,1,4,0)
 ;;=4^A81.00
 ;;^UTILITY(U,$J,358.3,20596,2)
 ;;=^5000409
 ;;^UTILITY(U,$J,358.3,20597,0)
 ;;=A81.01^^55^808^10
 ;;^UTILITY(U,$J,358.3,20597,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20597,1,3,0)
 ;;=3^Creutzfeldt-Jakob Disease,Variant
 ;;^UTILITY(U,$J,358.3,20597,1,4,0)
 ;;=4^A81.01
 ;;^UTILITY(U,$J,358.3,20597,2)
 ;;=^336701
 ;;^UTILITY(U,$J,358.3,20598,0)
 ;;=A81.89^^55^808^7
 ;;^UTILITY(U,$J,358.3,20598,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20598,1,3,0)
 ;;=3^Atypical Virus Infections of CNS NEC
 ;;^UTILITY(U,$J,358.3,20598,1,4,0)
 ;;=4^A81.89
 ;;^UTILITY(U,$J,358.3,20598,2)
 ;;=^5000413
 ;;^UTILITY(U,$J,358.3,20599,0)
 ;;=A81.2^^55^808^27
 ;;^UTILITY(U,$J,358.3,20599,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20599,1,3,0)
 ;;=3^Progressive Multifocal Leukoencephalopathy
 ;;^UTILITY(U,$J,358.3,20599,1,4,0)
 ;;=4^A81.2
 ;;^UTILITY(U,$J,358.3,20599,2)
 ;;=^5000411
 ;;^UTILITY(U,$J,358.3,20600,0)
 ;;=B20.^^55^808^17
 ;;^UTILITY(U,$J,358.3,20600,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20600,1,3,0)
 ;;=3^HIV Disease w/ Dementia w/ Behavioral Disturbances
 ;;^UTILITY(U,$J,358.3,20600,1,4,0)
 ;;=4^B20.
 ;;^UTILITY(U,$J,358.3,20600,2)
 ;;=^5000555^F02.81
 ;;^UTILITY(U,$J,358.3,20601,0)
 ;;=B20.^^55^808^18
 ;;^UTILITY(U,$J,358.3,20601,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20601,1,3,0)
 ;;=3^HIV Disease w/ Dementia w/o Behavioral Disturbances
 ;;^UTILITY(U,$J,358.3,20601,1,4,0)
 ;;=4^B20.
 ;;^UTILITY(U,$J,358.3,20601,2)
 ;;=^5000555^F02.80
 ;;^UTILITY(U,$J,358.3,20602,0)
 ;;=F10.27^^55^808^1
 ;;^UTILITY(U,$J,358.3,20602,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20602,1,3,0)
 ;;=3^Alcohol Dependence w/ Alcohol-Induced Persisting Dementia
 ;;^UTILITY(U,$J,358.3,20602,1,4,0)
 ;;=4^F10.27
 ;;^UTILITY(U,$J,358.3,20602,2)
 ;;=^5003095
 ;;^UTILITY(U,$J,358.3,20603,0)
 ;;=F19.97^^55^808^29
 ;;^UTILITY(U,$J,358.3,20603,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20603,1,3,0)
 ;;=3^Psychoactive Substance Use w/ Persisting Dementia NEC
 ;;^UTILITY(U,$J,358.3,20603,1,4,0)
 ;;=4^F19.97
 ;;^UTILITY(U,$J,358.3,20603,2)
 ;;=^5003465
 ;;^UTILITY(U,$J,358.3,20604,0)
 ;;=F03.90^^55^808^15
 ;;^UTILITY(U,$J,358.3,20604,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20604,1,3,0)
 ;;=3^Dementia w/o Behavioral Disturbance,Unspec
 ;;^UTILITY(U,$J,358.3,20604,1,4,0)
 ;;=4^F03.90
 ;;^UTILITY(U,$J,358.3,20604,2)
 ;;=^5003050
 ;;^UTILITY(U,$J,358.3,20605,0)
 ;;=G30.0^^55^808^2
 ;;^UTILITY(U,$J,358.3,20605,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20605,1,3,0)
 ;;=3^Alzheimer's Disease w/ Early Onset
 ;;^UTILITY(U,$J,358.3,20605,1,4,0)
 ;;=4^G30.0
 ;;^UTILITY(U,$J,358.3,20605,2)
 ;;=^5003805
 ;;^UTILITY(U,$J,358.3,20606,0)
 ;;=G30.1^^55^808^3
 ;;^UTILITY(U,$J,358.3,20606,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20606,1,3,0)
 ;;=3^Alzheimer's Disease w/ Late Onset
 ;;^UTILITY(U,$J,358.3,20606,1,4,0)
 ;;=4^G30.1
 ;;^UTILITY(U,$J,358.3,20606,2)
 ;;=^5003806
 ;;^UTILITY(U,$J,358.3,20607,0)
 ;;=G30.9^^55^808^4
 ;;^UTILITY(U,$J,358.3,20607,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20607,1,3,0)
 ;;=3^Alzheimer's Disease,Unspec
 ;;^UTILITY(U,$J,358.3,20607,1,4,0)
 ;;=4^G30.9
 ;;^UTILITY(U,$J,358.3,20607,2)
 ;;=^5003808
 ;;^UTILITY(U,$J,358.3,20608,0)
 ;;=G10.^^55^808^19
 ;;^UTILITY(U,$J,358.3,20608,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20608,1,3,0)
 ;;=3^Huntington's Disease w/ Dementia w/ Behavioral Disturbance
 ;;^UTILITY(U,$J,358.3,20608,1,4,0)
 ;;=4^G10.
 ;;^UTILITY(U,$J,358.3,20608,2)
 ;;=^5003751^F02.81
 ;;^UTILITY(U,$J,358.3,20609,0)
 ;;=G10.^^55^808^20
 ;;^UTILITY(U,$J,358.3,20609,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20609,1,3,0)
 ;;=3^Huntington's Disease w/ Dementia w/o Behavioral Disturbances
 ;;^UTILITY(U,$J,358.3,20609,1,4,0)
 ;;=4^G10.
 ;;^UTILITY(U,$J,358.3,20609,2)
 ;;=^5003751^F02.80
 ;;^UTILITY(U,$J,358.3,20610,0)
 ;;=G90.3^^55^808^21
 ;;^UTILITY(U,$J,358.3,20610,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20610,1,3,0)
 ;;=3^Multi-System Degeneration of the Autonomic Nervous System
 ;;^UTILITY(U,$J,358.3,20610,1,4,0)
 ;;=4^G90.3
 ;;^UTILITY(U,$J,358.3,20610,2)
 ;;=^5004162
 ;;^UTILITY(U,$J,358.3,20611,0)
 ;;=G91.2^^55^808^22
 ;;^UTILITY(U,$J,358.3,20611,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20611,1,3,0)
 ;;=3^NPH w/ Dementia w/ Behavioral Disturbances
 ;;^UTILITY(U,$J,358.3,20611,1,4,0)
 ;;=4^G91.2
 ;;^UTILITY(U,$J,358.3,20611,2)
 ;;=^5004174^F02.81
 ;;^UTILITY(U,$J,358.3,20612,0)
 ;;=G91.2^^55^808^23
 ;;^UTILITY(U,$J,358.3,20612,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20612,1,3,0)
 ;;=3^NPH w/ Dementia w/o Behavioral Disturbances
 ;;^UTILITY(U,$J,358.3,20612,1,4,0)
 ;;=4^G91.2
 ;;^UTILITY(U,$J,358.3,20612,2)
 ;;=^5004174^F02.80
 ;;^UTILITY(U,$J,358.3,20613,0)
 ;;=G30.8^^55^808^5
 ;;^UTILITY(U,$J,358.3,20613,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20613,1,3,0)
 ;;=3^Alzheimer's Diseases NEC
 ;;^UTILITY(U,$J,358.3,20613,1,4,0)
 ;;=4^G30.8
 ;;^UTILITY(U,$J,358.3,20613,2)
 ;;=^5003807
 ;;^UTILITY(U,$J,358.3,20614,0)
 ;;=G31.09^^55^808^16
 ;;^UTILITY(U,$J,358.3,20614,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20614,1,3,0)
 ;;=3^Frontotemporal Dementia NEC
 ;;^UTILITY(U,$J,358.3,20614,1,4,0)
 ;;=4^G31.09
 ;;^UTILITY(U,$J,358.3,20614,2)
 ;;=^329916
 ;;^UTILITY(U,$J,358.3,20615,0)
 ;;=G20.^^55^808^24
 ;;^UTILITY(U,$J,358.3,20615,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20615,1,3,0)
 ;;=3^Parkinson's Disease w/ Dementia w/ Behavioral Disturbances
 ;;^UTILITY(U,$J,358.3,20615,1,4,0)
 ;;=4^G20.
 ;;^UTILITY(U,$J,358.3,20615,2)
 ;;=^5003770^F02.81
 ;;^UTILITY(U,$J,358.3,20616,0)
 ;;=G20.^^55^808^25
 ;;^UTILITY(U,$J,358.3,20616,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20616,1,3,0)
 ;;=3^Parkinson's Disease w/ Dementia w/o Behavioral Disturbances
 ;;^UTILITY(U,$J,358.3,20616,1,4,0)
 ;;=4^G20.
 ;;^UTILITY(U,$J,358.3,20616,2)
 ;;=^5003770^F02.80
 ;;^UTILITY(U,$J,358.3,20617,0)
 ;;=G31.01^^55^808^26
 ;;^UTILITY(U,$J,358.3,20617,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20617,1,3,0)
 ;;=3^Pick's Disease
 ;;^UTILITY(U,$J,358.3,20617,1,4,0)
 ;;=4^G31.01
 ;;^UTILITY(U,$J,358.3,20617,2)
 ;;=^329915
 ;;^UTILITY(U,$J,358.3,20618,0)
 ;;=G23.1^^55^808^28
 ;;^UTILITY(U,$J,358.3,20618,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20618,1,3,0)
 ;;=3^Progressive Supranuclear Ophthalmoplegia
 ;;^UTILITY(U,$J,358.3,20618,1,4,0)
 ;;=4^G23.1
 ;;^UTILITY(U,$J,358.3,20618,2)
 ;;=^5003780
 ;;^UTILITY(U,$J,358.3,20619,0)
 ;;=Z79.2^^55^809^1
 ;;^UTILITY(U,$J,358.3,20619,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20619,1,3,0)
 ;;=3^Antibiotics
 ;;^UTILITY(U,$J,358.3,20619,1,4,0)
 ;;=4^Z79.2
 ;;^UTILITY(U,$J,358.3,20619,2)
 ;;=^321546
 ;;^UTILITY(U,$J,358.3,20620,0)
 ;;=Z79.01^^55^809^2
 ;;^UTILITY(U,$J,358.3,20620,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20620,1,3,0)
 ;;=3^Anticoagulants
 ;;^UTILITY(U,$J,358.3,20620,1,4,0)
 ;;=4^Z79.01
 ;;^UTILITY(U,$J,358.3,20620,2)
 ;;=^5063330
 ;;^UTILITY(U,$J,358.3,20621,0)
 ;;=Z79.02^^55^809^3
 ;;^UTILITY(U,$J,358.3,20621,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20621,1,3,0)
 ;;=3^Antiplatelets/Antithrombotics
 ;;^UTILITY(U,$J,358.3,20621,1,4,0)
 ;;=4^Z79.02
 ;;^UTILITY(U,$J,358.3,20621,2)
 ;;=^5063331
 ;;^UTILITY(U,$J,358.3,20622,0)
 ;;=Z79.82^^55^809^4
 ;;^UTILITY(U,$J,358.3,20622,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20622,1,3,0)
 ;;=3^Aspirin
 ;;^UTILITY(U,$J,358.3,20622,1,4,0)
 ;;=4^Z79.82
 ;;^UTILITY(U,$J,358.3,20622,2)
 ;;=^5063340
 ;;^UTILITY(U,$J,358.3,20623,0)
 ;;=Z79.4^^55^809^5
 ;;^UTILITY(U,$J,358.3,20623,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20623,1,3,0)
 ;;=3^Insulin
 ;;^UTILITY(U,$J,358.3,20623,1,4,0)
 ;;=4^Z79.4
 ;;^UTILITY(U,$J,358.3,20623,2)
 ;;=^5063334
 ;;^UTILITY(U,$J,358.3,20624,0)
 ;;=Z79.1^^55^809^7
 ;;^UTILITY(U,$J,358.3,20624,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20624,1,3,0)
 ;;=3^NSAID
 ;;^UTILITY(U,$J,358.3,20624,1,4,0)
 ;;=4^Z79.1
 ;;^UTILITY(U,$J,358.3,20624,2)
 ;;=^5063332
 ;;^UTILITY(U,$J,358.3,20625,0)
 ;;=Z79.891^^55^809^8
 ;;^UTILITY(U,$J,358.3,20625,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20625,1,3,0)
 ;;=3^Opiate Analgesic
 ;;^UTILITY(U,$J,358.3,20625,1,4,0)
 ;;=4^Z79.891
 ;;^UTILITY(U,$J,358.3,20625,2)
 ;;=^5063342
 ;;^UTILITY(U,$J,358.3,20626,0)
 ;;=Z79.51^^55^809^9
 ;;^UTILITY(U,$J,358.3,20626,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20626,1,3,0)
 ;;=3^Steroids-Inhaled
 ;;^UTILITY(U,$J,358.3,20626,1,4,0)
 ;;=4^Z79.51
 ;;^UTILITY(U,$J,358.3,20626,2)
 ;;=^5063335
 ;;^UTILITY(U,$J,358.3,20627,0)
 ;;=Z79.52^^55^809^10
 ;;^UTILITY(U,$J,358.3,20627,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20627,1,3,0)
 ;;=3^Steroids-Systemic
 ;;^UTILITY(U,$J,358.3,20627,1,4,0)
 ;;=4^Z79.52
 ;;^UTILITY(U,$J,358.3,20627,2)
 ;;=^5063336
 ;;^UTILITY(U,$J,358.3,20628,0)
 ;;=Z79.899^^55^809^6
 ;;^UTILITY(U,$J,358.3,20628,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20628,1,3,0)
 ;;=3^Long Term Current Drug Therapy NEC
 ;;^UTILITY(U,$J,358.3,20628,1,4,0)
 ;;=4^Z79.899
 ;;^UTILITY(U,$J,358.3,20628,2)
 ;;=^5063343
 ;;^UTILITY(U,$J,358.3,20629,0)
 ;;=99201^^56^810^1
 ;;^UTILITY(U,$J,358.3,20629,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,20629,1,1,0)
 ;;=1^Problem Focus
 ;;^UTILITY(U,$J,358.3,20629,1,2,0)
 ;;=2^99201
 ;;^UTILITY(U,$J,358.3,20630,0)
 ;;=99202^^56^810^2
 ;;^UTILITY(U,$J,358.3,20630,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,20630,1,1,0)
 ;;=1^Expanded Problem Focus
 ;;^UTILITY(U,$J,358.3,20630,1,2,0)
 ;;=2^99202
 ;;^UTILITY(U,$J,358.3,20631,0)
 ;;=99203^^56^810^3
 ;;^UTILITY(U,$J,358.3,20631,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,20631,1,1,0)
 ;;=1^Detailed
